At Ashion®, we provide personalized options for cancer treatment.

Ashion, a TGen® clinical lab, is a CAP-accredited and CLIA-certified clinical genomics testing laboratory committed to accelerating the adoption of precision medicine in mainstream oncology, leveraging years of scientific and clinical experience. We offer a wide range of testing capabilities to assist our Physicians, Health Systems, Research and Commercial partners to provide precision cancer treatments.

Our newest assay, the GEM ExTra, covers all DNA-coding regions (whole Exome) and includes full RNA analysis (Transcriptome) of the human genome, providing the most comprehensive genomic assessment available for clinical cancer testing.

Learn more about the GEM ExTra cancer test